Stroke prevention in patients with atrial fibrillation
dc.contributor.advisor | Pórszász, Róbert | |
dc.contributor.advisordept | Department of Pharmacology | hu_HU |
dc.contributor.author | El Ali, Jalal | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Drimba, László | |
dc.contributor.opponent | Szentmiklósi, József András | |
dc.contributor.opponentdept | Kenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztály | hu_HU |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.date.accessioned | 2017-01-06T07:46:55Z | |
dc.date.available | 2017-01-06T07:46:55Z | |
dc.date.created | 2016 | |
dc.description.abstract | This thesis aims to shed light over the newest treatment measures to prevent stroke in patients suffering from atrial fibrillation. Atrial fibrillation is a very complex disease with mutiple inter-relating causes culminating in rapid, seemingly disorganized atrial activation. If this dis-organized activity in the atrium leads to thrombus formation, stroke, a severe manifestation resulting inevitably in death of the patient, occurs. | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 40 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/233626 | |
dc.language.iso | en | hu_HU |
dc.subject | Atrial fibrillation | hu_HU |
dc.subject | Stroke | |
dc.subject | anticoagulation | |
dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
dc.title | Stroke prevention in patients with atrial fibrillation | hu_HU |